Latest "National Council for Behavioral Health and Massachusetts Chiefs of Police Association" News Stories

03:48 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "National Council for Behavioral Health and Massachusetts Chiefs of Police Association" found in our extensive news archives from over 250 global news sources.

More Information about National Council for Behavioral Health and Massachusetts Chiefs of Police Association on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about National Council for Behavioral Health and Massachusetts Chiefs of Police Association for you to read. Along with our medical data and news we also list National Council for Behavioral Health and Massachusetts Chiefs of Police Association Clinical Trials, which are updated daily. BioPortfolio also has a large database of National Council for Behavioral Health and Massachusetts Chiefs of Police Association Companies for you to search.

Showing "National Council Behavioral Health Massachusetts Chiefs Police Association" News Articles 1–25 of 31,000+

Thursday 21st February 2019

Cipla and Wellthy Therapeutics Announce Partnership to Offer Digital Therapeutics for Diabetes and Cardiovascular Diseases

MUMBAI, India, Feb. 21, 2019/PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") and Wellthy Therapeutics Private Limited ("Wellthy Therapeutics") today announced that they have entered into a partnership to offer a combination of pharmacotherapy and digital therapeutics for improved patient outcomes in the chronic therapies of Diabet...

OptiBiotix Health cholesterol product generally recognised as safe (GRAS) by US independent expert panel

OptiBiotix chief executive Stephen O’Hara said: “This is a significant achievement and a major commercial milestone as it expands the potential applications of LPLDL from use as a supplement to use as a functional ingredient"

PureTech Health to Present at Two Upcoming Investor Conferences

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) Axis, today announced two presentations at upcoming investor conferences. Daphne Zohar, co-founder and chief executive officer, will present at the SVB Leerink Global Healthcare Conf...

FDA Places XNCR Trial On Hold, ABIO Abuzz, Mark Your Calendar For SRPT

Today's Daily Dose brings you news about Achieve Life Sciences' progress in ORCA-1 trial; Agios Pharma's near-term regulatory catalyst; new development related to ARCA biopharma's PRECISION-AF pivotal study; financial outlook of Genomic Health and NuVasive; near-term clinical trial catalyst of Sarepta; and partial clinical hold on Xencor's phase I acute myeloid leukemia trial.

Wednesday 20th February 2019

A National Healthcare Predicament: Most PCPs Are Not Involved in Managing the Top 10 Medical Conditions with Significant Practice Variations

Primary care physicians (PCPs) need to become more active participants in treating the Top 10 medical conditions with significant practice variations. “Nationally, PCPs are solely involved in treating less than 25% of medical condition episodes with the most practice variations,” stated Dr. Douglas G. Cave, President of

Mark Gordon, Clinical Researcher, is Newest Hire to Join Newport-Mesa Audiology Balance & Ear Institute

Gordon will expand the scientific research surrounding vestibular audiology to continue to improve the development and implementation of the most clinically advanced approaches to diagnosing and treating vestibular dysfunction. Gordon’s research will advance the use of the Institute’s proprietary Advanced Vestibular Treatment™ (AVT) in treating patients with dizziness, vertigo and balance di...

[Articles] Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

CNS cancer is responsible for substantial morbidity and mortality worldwide, and incidence increased between 1990 and 2016. Significant geographical and regional variation in the incidence of CNS cancer might be reflective of differences in diagnoses and reporting practices or unknown environmental and genetic risk factors. Future efforts are needed to analyse CNS cancer burden by subtype.

Doctors call on UK to be carbon neutral by 2030

Health professionals from a range of disciplines have called on UK parliamentarians to legislate urgently for the UK to be carbon neutral by 2030.In an open letter published in The BMJ and the Lancet...

Drug Prices Based On Success Could Speed Up Cancer Patients' Treatment

Press release Paying for cancer drugs based on how well they work in practice could help patients get new treatments faster, according to a Cancer Research UK report published today. "Ensuring cutting-edge medicines reach patients as quickly as possible is vital if we’re to achieve our ambition of three in four patients surviving their cancer by 2034." Emlyn Samuel, Cancer Research UK As we...

Samsung pushes into health wearables fray with newly announced smartwatches

The company’s new Galaxy Active smartwatch upgrades its Galaxy Watch capabilities with increased health monitoring capabilities including blood pressure tracking, alongside standard fitness wearable features like hear

New robotic sensor technology can diagnose reproductive health problems in real-time

(Imperial College London) Researchers have developed new robotic sensor technology that has the capability to diagnose women's reproductive health problems in real-time.

Two types of HPV linked to cervical cancer have declined since the advent of the HPV vaccine

(American Association for Cancer Research) An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease. The study offers evidence that HPV vaccination reduced the incidence of infections that can lead to cervical cancer.

Mayo Clinic researchers review modern cases of leprosy

(Mayo Clinic) Leprosy has a history that has spanned centuries and societies across the globe. Yet, it continues to be a problem -- even in the modern era. Sufferers from the chronic and infectious skin disease still face the social stigma and lack of medical care that people have endured since the origins of the disease itself. Although leprosy can be treated, the World Health Organization report...

10 Highly Effective Ways to Instantly Lower Your Stress Levels on the Job

Excessive stress in the workplace can have devastating effects on your productivity and job satisfaction levels, your performance, and your overall health and wellbeing.

$22m program to fund early-stage disease research

The Australian Government is providing more than $22 million for important early-stage research that will lead to new interventions, cures and treatments of major diseases. Major diseases — like arthritis, asthma, back pain, cancer, cardiovascular disease, chronic obstructive pulmonary disease, diabetes and mental health conditions — have a severe impact on the quality of life for Australians...

Teenagers Say Depression and Anxiety Are Major Issues Among Their Peers

A Pew Research Center survey found that teenagers across all demographic groups grapple with mental health issues.

[Correspondence] Legislate for carbon net zero by 2030

On Nov 29, 2018, the UK Health Alliance on Climate Change, of which the Climate and Health Council, BMJ, and The Lancet are members, sent a letter1 to the UK Prime Minister saying that for the preservation of both planetary and human health, the UK must become carbon net zero before 2050. Given the recent warning from Sir David Attenborough2 of the risk of civilisational breakdown, and the increas...

Sanofi Clarifies Xyzal-Zyrtec Size Comparison, Outweighs J&J Calculation

National Advertising Division recommends Sanofi add "nearly" to claim that Xyzal Allergy 24HR is "as effective at half the size"...   

STAT Plus: Unsealed testimony reveals a goal of Atul Gawande venture: ‘Make health insurance intelligible’

Making insurance intelligible is the mission of the health care venture led by Atul Gawande and founded by Amazon, Berkshire Hathaway, and J.P. Morgan Chase, testimony reveals.

Renowned Pharmaceutical R&D Expert Jan Lundberg Joins Metabolon’s Board of Directors

Metabolon, the world leader in metabolomics, today announced that Dr. Jan Lundberg, Ph.D. has joined its Board of Directors. Dr. Lundberg brings significant experience leading large global research and development organizations, most recently as President of Lilly Research Labs and Head of R&D at Eli Lilly. Lundberg will serve as an independent directo...

The Medical Tech that Helps You When Your Doctor Can’t

A new breed of tech company wants to fill the gaps between you, your doctor and your health insurance.

Teleflex Awarded SURPASS Agreement with Premier

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has been awarded a group purchasing agreement for SURPASS with Premier. Effective January 1, 2019, the new agreement offers Teleflex’s broad range of respiratory disposable products to Premier members. “This highly committed purc...

U.S. health spending to rise 5.5 percent per year over next decade: CMS

U.S. health spending is expected to grow at an average rate of 5.5 percent every year from 2018 over the next decade and will reach nearly $6 trillion by 2027 as more people become eligible for Medicare, a government health agency said on Wednesday. ...

Japan is nearing approval for a pair of highly anticipated gene therapies, but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments. 

Japan is nearing approval for a pair of highly anticipated gene therapies, but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments. 

Graphnet, Inc. Awarded Damages by a Jury for Defamation in a Lawsuit Against Retarus, Inc.

Graphnet, Inc., an industry leader providing secure cloud-based enterprise content management solutions and integrated electronic messaging services, sued Retarus, Inc. (“Retarus”), for defamation. Graphnet’s defamation claim [Docket No. HUD-L-3298-16] was presented to a jury in Hudson County Superior Court on January 28, 29, 30 and 31, 2019 and Febr...

Quick Search


News Quicklinks